Immunic, Inc. Severance Costs
Immunic, Inc. (IMUX) reported Severance Costs of $6.37 million for the 3-month period ending 2019-03-31, per its 10-Q filed 2019-04-10.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SeveranceCosts1 · last filed 2019-04-10
- Immunic, Inc. severance costs for the quarter ending 2019-03-31 was $6.37M.
- Immunic, Inc. severance costs for the quarter ending 2018-12-31 was $0.00.
- Immunic, Inc. severance costs for the quarter ending 2018-09-30 was $2.40M.
- Immunic, Inc. severance costs for the quarter ending 2018-06-30 was $0.00.
- Immunic, Inc. severance costs for fiscal 2018 was $2.40M.
- Immunic, Inc. severance costs for fiscal 2017 was $0.00.
- Immunic, Inc. severance costs for fiscal 2016 was $0.00.
| Period end | Severance Costs 3 month | Severance Costs 6 month | Severance Costs 9 month | Severance Costs 12 month |
|---|---|---|---|---|
| 2019-03-31 | $6.37M 10-Q · filed 2019-04-10 | $6.37M derived: sum of 2 quarters · filed 2019-04-10 | $8.76M derived: sum of 3 quarters · filed 2019-04-10 | $8.76M derived: sum of 4 quarters · filed 2019-04-10 |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-04 | $2.40M derived: sum of 2 quarters · filed 2019-03-04 | $2.40M derived: sum of 3 quarters · filed 2019-03-04 | $2.40M 10-K · filed 2019-03-04 |
| 2018-09-30 | $2.40M 10-Q · filed 2018-11-08 | $2.40M derived: sum of 2 quarters · filed 2019-03-04 | $2.40M 10-Q · filed 2018-11-08 | $2.40M derived: sum of 4 quarters · filed 2019-04-10 |
| 2018-06-30 | $0.00 derived: 10-K 12 month − 3 quarters · filed 2019-03-04 | $0.00 derived: sum of 2 quarters · filed 2019-04-10 | $0.00 derived: sum of 3 quarters · filed 2019-04-10 | $0.00 derived: sum of 4 quarters · filed 2019-04-10 |
| 2018-03-31 | $0.00 10-Q · filed 2019-04-10 | $0.00 derived: sum of 2 quarters · filed 2019-04-10 | $0.00 derived: sum of 3 quarters · filed 2019-04-10 | |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-04 | $0.00 derived: sum of 2 quarters · filed 2019-03-04 | $0.00 10-K · filed 2019-03-04 | |
| 2017-09-30 | $0.00 10-Q · filed 2018-11-08 | $0.00 10-Q · filed 2018-11-08 | ||
| 2016-12-31 | $0.00 10-K · filed 2019-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B |